Login / Signup

A phase II single-arm study of pembrolizumab with enzalutamide in men with metastatic castration-resistant prostate cancer progressing on enzalutamide alone.

Julie N GraffTomasz M BeerJoshi J AlumkalRachel E SlottkeWilliam L RedmondGeorge V ThomasReid F ThompsonMary A WoodYoshinobu KoguchiYiyi ChenEmile LatourRaymond C BerganCharles G DrakeAmy E Moran
Published in: Journal for immunotherapy of cancer (2021)
clinicaltrials.gov (NCT02312557).
Keyphrases
  • phase ii
  • prostate cancer
  • clinical trial
  • open label
  • squamous cell carcinoma
  • small cell lung cancer
  • randomized controlled trial
  • double blind
  • middle aged
  • placebo controlled
  • study protocol